Pharmacologic Effect for Female Overactive Bladder Syndrome: Mirabegron Versus Solifenacin
Clinical trial NCT04023253 · UNKNOWN
Trial details
- NCT number
- NCT04023253
- Sponsor
- Far Eastern Memorial Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-01
- Primary completion
- 2024-12-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.